| Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor. (NCT05411380) | wang shusen | 2022-10-03 |
| Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). (NCT05961644) | Institute of Psychiatry and Neurology, Warsaw | 2022-10-03 |
| A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas (NCT05387733) | Caliway Biopharmaceuticals Co., Ltd. | 2022-10-03 |
| A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose. (NCT05463419) | Yisheng Biopharma (Singapore) Pte. Ltd. | 2022-10-03 |
| A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer (NCT05570253) | Memorial Sloan Kettering Cancer Center | 2022-10-03 |
| Camostat Mesylate for Protein-losing Enteropathy After Fontan Operation (NCT05474664) | Seoul National University Hospital | 2022-10-03 |
| Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older (NCT05553301) | Sanofi Pasteur, a Sanofi Company | 2022-10-03 |
| A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer (NCT05005273) | Bristol-Myers Squibb | 2022-10-03 |
| Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia (NCT06146881) | Indonesia University | 2022-10-02 |
| Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care (NCT05205928) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2022-10-02 |
| Effectiveness of PRP, Conditioned Medium UC-MSCs Secretome and Hyaluronic Acid for the Treatment of Knee Osteoarthritis (NCT05579665) | Universitas Sriwijaya | 2022-10-02 |
| The Use of Cannabinoid Patch for Knee Osteoarthritis (NCT04412837) | Northwell Health | 2022-10-01 |
| Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence (NCT05611645) | Huashan Hospital | 2022-10-01 |
| AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma (NCT05594914) | The First Affiliated Hospital of University of South China | 2022-10-01 |
| Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug (NCT04810104) | King's College London | 2022-10-01 |
| Aspirin for Prophylaxis of TTP (NCT05568147) | The First Affiliated Hospital of Soochow University | 2022-10-01 |
| AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC (NCT05522894) | Chinese Academy of Medical Sciences | 2022-10-01 |
| A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma. (NCT05594381) | The First Affiliated Hospital with Nanjing Medical University | 2022-10-01 |
| COVID-19 Paediatric VLA2001-321 Study (NCT05298644) | Valneva Austria GmbH | 2022-10-01 |
| A Study of Olverembatinib in the Treatment of Ph+ ALL (NCT05466175) | Chen Suning | 2022-10-01 |
| Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome (NCT05383677) | University Medical Center Groningen | 2022-10-01 |
| Breast Stimulation vs. Low Dose Oxytocin Augmentation for Labor Induction (NCT05510310) | Western Galilee Hospital-Nahariya | 2022-10-01 |
| High-dose Vitamin D Supplement for the Prevention of Acute Asthma-like Symptoms in Preschool Children (NCT05043116) | Copenhagen Studies on Asthma in Childhood | 2022-10-01 |
| Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status (NCT05409417) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-10-01 |
| Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease (NCT05670912) | Capital Medical University | 2022-10-01 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous AGX-201 for Migraine Prophylaxis (NCT02021474) | AgoneX Biopharmaceuticals, Inc. | 2022-10-01 |
| Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC (NCT05544253) | West China Hospital | 2022-10-01 |
| As a Second-line Treatment for Metastatic Gastric Adenocarcinoma Patients, the Safety and Effective of Vactosertib Administration in Combination With Paclitaxel+Ramucirumab is Evaluated, and a Phase 2a Clinical Trial to Biomarkers (NCT04656002) | Samsung Medical Center | 2022-10-01 |
| Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC (NCT05548504) | Odense University Hospital | 2022-10-01 |
| GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer (NCT05575804) | Fudan University | 2022-10-01 |
| Study of SM-88 in Advanced Cancers (NCT02562612) | Tyme, Inc | 2022-10-01 |
| The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients (NCT04731051) | King Hussein Cancer Center | 2022-10-01 |
| Lesion Sterilization And Tissue Repair Versus Zinc Oxide And Eugenol For Treatment of Necrotic Primary Molars (NCT05448937) | Cairo University | 2022-10-01 |
| Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age (NCT05391555) | University of California, San Francisco | 2022-10-01 |
| A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis (NCT05525715) | E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | 2022-10-01 |
| Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies (NCT05570188) | Kunming Hope of Health Hospital | 2022-10-01 |
| DIAgnosing GDM usiNg Oral Sugar InStead (NCT05115188) | Sunnybrook Health Sciences Centre | 2022-10-01 |
| Comparative Study of Different Doses of Magnesium as a Protective Agent in Nephrotoxicity in Cancer Patients (NCT05586009) | Tanta University | 2022-10-01 |
| Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer (NCT05503888) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-10-01 |
| Single Dose Aminoglycosides for Acute Uncomplicated Cystitis in the Emergency Department Setting (NCT05702762) | Mercy Health Ohio | 2022-10-01 |
| A Study of Oncobax®-AK in Patients With Advanced Solid Tumors (NCT05865730) | EverImmune | 2022-10-01 |
| A Multicenter Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITP (NCT05411874) | Shandong University | 2022-10-01 |
| Quinidine Versus Verapamil in Short-coupled Idiopathic Ventricular Fibrillation (NCT05593757) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2022-10-01 |
| A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer (NCT05444374) | Sichuan Cancer Hospital and Research Institute | 2022-10-01 |
| Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer (NCT05215379) | Changhai Hospital | 2022-10-01 |
| Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases (NCT05588297) | Shanghai Changzheng Hospital | 2022-10-01 |
| BV-AVD-R Treatment Children Hodgkin's Lymphoma (NCT06201507) | Beijing Children's Hospital | 2022-10-01 |
| Role of Intermittent Exogenous Ketosis in the Physiological and Muscular Adaptive Response to Endurance Training (NCT05932420) | KU Leuven | 2022-10-01 |
| Fucoidan Assisted Eradication of Helicobacter Pylori (NCT05461508) | Nanjing First Hospital, Nanjing Medical University | 2022-10-01 |
| Study to Evaluate the Efficacy of Afatinib in Skull Base Chordoma (NCT05519917) | Huashan Hospital | 2022-10-01 |
| SGLT2 Inhibition in Hemodialysis (NCT05179668) | Medical University of Vienna | 2022-10-01 |
| Bacteriophage Therapy in Patients With Prosthetic Joint Infections (NCT04787250) | Adaptive Phage Therapeutics, Inc. | 2022-10-01 |
| Fluzoparib Combined With Camrelizumab for Neoadjuvant Treatment of Embryogenic BRCA Mutation HER2 Negative Breast Cancer: an Open, Single Arm, Multicenter Study (NCT05576389) | Peking University People's Hospital | 2022-10-01 |
| A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma (NCT05527275) | Sun Yat-sen University | 2022-10-01 |
| Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE) (NCT05556083) | Al-Azhar University | 2022-10-01 |
| Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients (NCT06202001) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-10-01 |
| Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER) (NCT05640778) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-10-01 |
| Cannabidiol in Youth Alcohol Use Disorder (NCT05317546) | Medical University of South Carolina | 2022-10-01 |
| Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer (NCT05845268) | Beijing Friendship Hospital | 2022-10-01 |
| Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer (NCT05679050) | Tianjin Medical University Cancer Institute and Hospital | 2022-10-01 |
| Preemptive Analgesia Combination of Celecoxib and Pregabalin in THA (NCT05509946) | Indonesia University | 2022-10-01 |
| Evaluation of Intravascular Irradiation of Blood in Children With Sleep Bruxism (NCT05301452) | University of Nove de Julho | 2022-10-01 |
| Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM (NCT05408026) | Alliance Foundation Trials, LLC. | 2022-10-01 |
| Azacytidine During Anti-tuberculosis Therapy (NCT03941496) | Andrew Dinardo | 2022-10-01 |
| Ketohexokinase Inhibition in NAFLD (NCT05463575) | Maastricht University Medical Center | 2022-10-01 |
| SPEL as Introductive Treatment Following Immune-chemotherapy as Consolidated Therapy for R/R DLBCL With p53 and/or c-Myc Expression (NCT05498636) | The Affiliated Hospital of Qingdao University | 2022-10-01 |
| CAV Regimen for R/R AML (NCT05657639) | The First Affiliated Hospital of Soochow University | 2022-10-01 |
| Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors (NCT05760196) | Xiangpan Li | 2022-10-01 |
| Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy (NCT05243654) | Oxford University Clinical Research Unit Indonesia | 2022-10-01 |
| 6MW3511 in Patients With Advanced Solid Tumor (NCT05524194) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-10-01 |
| Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL (NCT05571540) | Kunming Hope of Health Hospital | 2022-10-01 |
| Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma (NCT05389527) | Shanghai Zhongshan Hospital | 2022-09-30 |
| Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy (NCT05700097) | Beijing Tiantan Hospital | 2022-09-30 |
| Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients (NCT05823701) | The First Affiliated Hospital of Soochow University | 2022-09-30 |
| Onvansertib + Paclitaxel In TNBC (NCT05383196) | Antonio Giordano, MD | 2022-09-30 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH (NCT05462353) | Gannex Pharma Co., Ltd. | 2022-09-30 |
| A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies (NCT05443126) | Ellipses Pharma | 2022-09-30 |
| The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action (NCT05414409) | Heba M. Ismail | 2022-09-30 |
| A Umbrella Study in R/R PTCL Guided by Molecular Subtypes (NCT05559008) | Ruijin Hospital | 2022-09-30 |
| TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps (NCT04998305) | Hiroshi Mitsumoto | 2022-09-30 |
| A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer (NCT05566574) | Memorial Sloan Kettering Cancer Center | 2022-09-30 |
| Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia (NCT03852992) | University of Minnesota | 2022-09-30 |
| A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC (NCT05543330) | Wuhan YZY Biopharma Co., Ltd. | 2022-09-30 |
| Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD) (NCT05509023) | Q32 Bio Inc. | 2022-09-30 |
| A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC (NCT05775874) | Abbisko Therapeutics Co, Ltd | 2022-09-30 |
| A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors (NCT04614766) | David Bushnell | 2022-09-30 |
| Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy (NCT05536596) | Universitat Internacional de Catalunya | 2022-09-30 |
| HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (NCT05535933) | Hutchmed | 2022-09-30 |
| T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors (NCT05200559) | Alexander B Olawaiye, MD | 2022-09-30 |
| Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants (NCT05584202) | ModernaTX, Inc. | 2022-09-30 |
| Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy (NCT05283226) | NATCO Pharma Ltd. | 2022-09-30 |
| Safety, Tolerability, and Efficacy of Immunomodulation With AT-1501 in Combination With Transplanted Islet Cells in Adults With Brittle T1D (NCT05480657) | Eledon Pharmaceuticals | 2022-09-30 |
| A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease (NCT05499130) | Teva Branded Pharmaceutical Products R&D, Inc. | 2022-09-30 |
| Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors (NCT05527821) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-09-30 |
| Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma (NCT05539118) | Xijing Hospital | 2022-09-30 |
| QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC (NCT05799820) | Qilu Pharmaceutical Co., Ltd. | 2022-09-29 |
| EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T (NCT05521412) | Peter MacCallum Cancer Centre, Australia | 2022-09-29 |
| The Dynamic Monitoring of Cerebrospinal Fluid ctDNA (NCT06315686) | Jiangsu Province Nanjing Brain Hospital | 2022-09-29 |
| Acetate and Age-associated Arterial Dysfunction (NCT05424263) | University of Colorado, Denver | 2022-09-29 |
| Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia (AML) (NCT05319587) | Moleculin Biotech, Inc. | 2022-09-29 |